Market Cap

Bio-Gene Technology Limited Market Capitalization:

A$11.9 Million

AUD as of Jan. 1, 2024

US$8.1 Million

business Bio-Gene Technology Limited Company Profile

Bio-Gene Technology Limited Main Stock Listing

ASX: BGT

Market Capitalization History of Bio-Gene Technology Limited

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Biotechnology
Company Market Cap (USD)
Novo Nordisk $461.52 B
Vertex Pharmaceuticals Incorporated $107.23 B
Regeneron Pharmaceuticals, Inc. $100.01 B
CSL Limited $94.74 B
Marinomed Biotech AG $73.23 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $586.39 B
UnitedHealth Group $504.47 B
Novo Nordisk $461.52 B
Johnson & Johnson $387.50 B
Merck $296.51 B

Yearly evolution of Bio-Gene Technology Limited market cap

Date Market Cap YoY Change
Jan. 1, 2024 A$11.9 M -39.68%
Jan. 1, 2023 A$19.7 M -52.17%
Jan. 1, 2022 A$41.2 M 58.62%
Jan. 31, 2021 A$26.0 M 7.41%
Jan. 1, 2021 A$24.2 M -18.18%
Jan. 31, 2020 A$29.5 M -8.33%
Jan. 1, 2020 A$32.2 M 80.00%
Jan. 31, 2019 A$17.9 M -13.04%
Jan. 1, 2019 A$20.6 M -39.47%
Jan. 31, 2018 A$34.0 M -2.56%
Jan. 1, 2018 A$34.9 M

Market capitalization is calculated from the opening stock price at the beginning of each year.

Top 1-year algo backtest: +269.94%

$10,000 in May 2023 would now be $36,994 by following this algorithm daily at market close.

Boost your stocks returns with Disfold AI... Now!

Try Disfold AI for FREE

Bio-Gene Technology Limited Categories

Australia languages Healthcare languages Biotechnology
Australia Healthcare Australia Biotechnology

Stocks & Indices

Bio-Gene Technology Limited has the following listings and related stock indices.


Stock: ASX: BGT

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.